SO

Sarah O’Dowd

Independent Director at Protagonist Therapeutics

Ms. O’Dowd has recently joined us in August 2020 as an independent member of our board of directors. From September 2008 to March 2020 she served as Senior Vice President, Chief Legal Officer and Secretary of Lam Research Corporation, an S&P 500 company. She also served as its VP of Global Human Resources from March 2009 to May 2012. From February 2007 to August 2008 she served as Vice President and General Counsel of FibroGen, Inc. She has advised multiple public and private life science companies on M&A, strategic transactions and governance, including ALZA Corporation, Jazz Pharmaceuticals, Corcept Therapeutics, Adeza BioMedical, and Threshold Pharmaceuticals. She also serves on the board of directors of Ichor Corporation. She received a J.D. and an M.A. in Communications from Stanford University and an A.B. in Mathematics from Immaculata College.

Timeline

  • Independent Director

    Current role